About: Funapide

An Entity of Type: book, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

Funapide (INN) (former developmental code names TV-45070 and XEN402) is a novel analgesic under development by (formerly in partnership with Teva Pharmaceutical Industries) for the treatment of a variety of chronic pain conditions, including osteoarthritis, neuropathic pain, postherpetic neuralgia, and erythromelalgia, as well as dental pain. It acts as a small-molecule Nav1.7 and Nav1.8 voltage-gated sodium channel blocker. Funapide is being evaluated in humans in both oral and topical formulations, and as of July 2014, has reached phase IIb clinical trials.

Property Value
dbo:abstract
  • Funapide (INN) (former developmental code names TV-45070 and XEN402) is a novel analgesic under development by (formerly in partnership with Teva Pharmaceutical Industries) for the treatment of a variety of chronic pain conditions, including osteoarthritis, neuropathic pain, postherpetic neuralgia, and erythromelalgia, as well as dental pain. It acts as a small-molecule Nav1.7 and Nav1.8 voltage-gated sodium channel blocker. Funapide is being evaluated in humans in both oral and topical formulations, and as of July 2014, has reached phase IIb clinical trials. (en)
dbo:casNumber
  • 1259933-16-8
dbo:fdaUniiCode
  • A5595LHJ2L
dbo:kegg
  • D11156
dbo:pubchem
  • 49836093
dbo:thumbnail
dbo:wikiPageExternalLink
dbo:wikiPageID
  • 43348294 (xsd:integer)
dbo:wikiPageLength
  • 4333 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID
  • 1082990349 (xsd:integer)
dbo:wikiPageWikiLink
dbp:atcPrefix
  • None (en)
dbp:c
  • 22 (xsd:integer)
dbp:casNumber
  • 1259933 (xsd:integer)
dbp:chemspiderid
  • 34500834 (xsd:integer)
dbp:f
  • 3 (xsd:integer)
dbp:h
  • 14 (xsd:integer)
dbp:iupacName
  • -1 (xsd:integer)
dbp:kegg
  • D11156 (en)
dbp:n
  • 1 (xsd:integer)
dbp:o
  • 5 (xsd:integer)
dbp:pubchem
  • 49836093 (xsd:integer)
dbp:routesOfAdministration
dbp:smiles
  • C1C2C5=CC6=COCO6 (en)
dbp:stdinchi
  • 1 (xsd:integer)
dbp:stdinchikey
  • NEBUOXBYNAHKFV-NRFANRHFSA-N (en)
dbp:unii
  • A5595LHJ2L (en)
dbp:width
  • 250 (xsd:integer)
dbp:wikiPageUsesTemplate
dcterms:subject
gold:hypernym
rdf:type
rdfs:comment
  • Funapide (INN) (former developmental code names TV-45070 and XEN402) is a novel analgesic under development by (formerly in partnership with Teva Pharmaceutical Industries) for the treatment of a variety of chronic pain conditions, including osteoarthritis, neuropathic pain, postherpetic neuralgia, and erythromelalgia, as well as dental pain. It acts as a small-molecule Nav1.7 and Nav1.8 voltage-gated sodium channel blocker. Funapide is being evaluated in humans in both oral and topical formulations, and as of July 2014, has reached phase IIb clinical trials. (en)
rdfs:label
  • Funapide (en)
owl:sameAs
prov:wasDerivedFrom
foaf:depiction
foaf:isPrimaryTopicOf
is dbo:wikiPageRedirects of
is dbo:wikiPageWikiLink of
is foaf:primaryTopic of
Powered by OpenLink Virtuoso    This material is Open Knowledge     W3C Semantic Web Technology     This material is Open Knowledge    Valid XHTML + RDFa
This content was extracted from Wikipedia and is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License